Amylyx Pharmaceuticals (AMLX) Earnings Date & Reports
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
AMLX is expected to report earnings to rise 5.08% to -38 cents per share on April 01
Q4'25
Est.
$-0.39
Q3'25
Beat
by $0.08
Q2'25
Est.
$-0.46
Q1'25
Beat
by $0.20
Q4'24
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -37 cents, beating the estimate of -44 cents. With 1.05M shares outstanding, the current market capitalization sits at 1.36B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AMLX showed earnings on November 06, 2025. You can read more about the earnings report here.